#news #biotech AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect .AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect
ntaylor
Wed, 09/29/2021 – 05:09

from FierceBiotech: Biotech https://ift.tt/39Pzgga